Iovance Biotherapeutics (IOVA) Gross Profit (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Gross Profit of $28.9 million for Q1 2026, up 337.77% year-over-year from $6.6 million in Q1 2025, and down 33.73% quarter-over-quarter from $43.7 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Gross Profit (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Gross Profit for 4 consecutive years, with $28.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 337.77% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at $104.9 million (up 51.33% YoY), while the FY2025 annual figure was $90.3 million, up 27.53% from the prior year.
- Gross Profit eased to $28.9 million in Q1 2026 per IOVA's latest filing, from $43.7 million in the prior quarter.
- Across five years, Gross Profit topped out at $43.7 million in Q4 2025 and bottomed at -$6.5 million in Q1 2024.
- Historically, Gross Profit has averaged $14.0 million across 4 years, with a median of $6.2 million in 2023.
- On a YoY basis, Gross Profit climbed as much as 1354.96% in 2025 and fell as far as 7.18% in 2025.
- Iovance Biotherapeutics' Gross Profit stood at $5.8 million in 2023, then soared by 514.92% to $35.9 million in 2024, then grew by 21.6% to $43.7 million in 2025, then tumbled by 33.73% to $28.9 million in 2026.
- Business Quant data shows IOVA's Gross Profit at $28.9 million in Q1 2026, $43.7 million in Q4 2025, and $29.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.72 Mn |
| Jun 30, 2026 | 55.72 Mn |
| Mar 31, 2026 | 28.93 Mn |
| Mar 31, 2026 | 28.93 Mn |
| Dec 31, 2025 | 43.66 Mn |
| Dec 31, 2025 | 43.66 Mn |
| Sep 30, 2025 | 28.98 Mn |
| Sep 30, 2025 | 28.98 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Dec 31, 2024 | 35.91 Mn |
| Dec 31, 2024 | 35.91 Mn |
| Sep 30, 2024 | 27.04 Mn |
| Sep 30, 2024 | 27.04 Mn |
| Jun 30, 2024 | -262,000.00 |
| Jun 30, 2024 | -262,000.00 |
| Mar 31, 2024 | -6.55 Mn |
| Mar 31, 2024 | -6.55 Mn |